H19 and hydrops fetalis: In summation, these reasonable findings enabled us to postulate a molecular mechanism that underlie DFU therapy by which HF-MSC-released exosomal lncRNA H19 suppresses inflammation, enhances proliferation and migration, and suppresses apoptosis of fibroblasts, thus ameliorating the damage of DFU and speeding up the process of wound healing.